Novartis Pharma US

      
TOBI is made for patients with cystic fibrosis to manage Pseudomonas aeruginosa (Pa) infections.

TOBI® (Tobramycin Inhalation Solution, USP)     is a special form of tobramycin     that is inhaled. It's the only tobramycin solution approved by the FDA for inhalation     . TOBI is a
sterile     solution and free from preservatives    .

When taken according to the directions, TOBI can help to improve lung function.

The important thing to remember is that TOBI is most effective when it's taken the right way. Because TOBI is a special type of medicine, there are specific instructions to follow. To get the best results when using TOBI, it helps to know:

How is TOBI administered?
What is the TOBI treatment cycle?
What does TOBI look like?
Why stick with TOBI?
What should parents know about TOBI?
 
How is TOBI administered?
   
TOBI is most effective when you take it the right way. Click here to see a video demonstration.  
   

What's the right way to say it? Click on the speaker icons Audio to hear how different words are pronounced. Make sure the speakers are turned up!
 
These words are also
defined in the glossary.
 
   
 
   
 
 
Home  |  CF and Pa Infections  |  TOBI Basics  |  Treating With TOBI  |  TOBI Tools and Tips
TOBI Patient Assistance  |  Cystic Fibrosis Resources  |  Glossary of Important CF Words  |  FAQs
Get More Information  |  Prescribing Information  |  Important Safety Information  | Send an E-card
CFvoice.com
Contact Us |  Site Map |  Site Guide

Please see full Prescribing Information.

Please see Patient Prescribing Information.

Information for Patients and Caregivers
Indication
TOBI® (Tobramycin Inhalation Solution, USP) is a prescription inhaled medication for cystic fibrosis patients whose lungs contain bacteria called Pseudomonas aeruginosa. TOBI has not been studied in patients under 6 years of age, in those with a lung function outside of a certain range, or in those whose lungs contain bacteria called Burkholderia cepacia. Ask your doctor if TOBI is right for you.

IMPORTANT SAFETY INFORMATION
If you are allergic to antibiotics in the same family as TOBI (ie, aminoglycosides), you should not take TOBI. Tell your doctor before starting treatment if you have any history of hearing, kidney, balance, or muscle problems.

Patients taking TOBI may have temporary side effects like coughing or difficulty breathing. Some people taking TOBI experienced ringing in the ears, hearing loss, or changes in voice (hoarseness)   . Ringing in the ears may be a warning sign for hearing loss. If you have ringing in the ears, changes in hearing, or dizziness, you should tell your doctor.

In studies, kidney damage was not seen in patients taking TOBI. However, antibiotics in the same family as TOBI have been linked to kidney damage.

If you are pregnant, plan to become pregnant, or if you are breast-feeding, talk with your doctor before taking TOBI.

Some drugs may interact with TOBI. Discuss all medications you are taking with your doctor.

Patients with cystic fibrosis can have many symptoms. Some of these may be related to your medications. You should tell your doctor if you have new or worsening symptoms.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

TBI-800101-B
Novartis Pharma US Use of Web site is governed by the Terms of Use and Privacy Statement.
Copyright © 2010
Novartis Pharmaceuticals Corporation. All rights reserved.
Novartis proudly supports the Patient Assistance Now program.